Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 2
2015 7
2016 6
2017 9
2018 10
2019 21
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review.
Dimitrakopoulou-Strauss A, Ronellenfitsch U, Cheng C, Pan L, Sachpekidis C, Hohenberger P, Henzler T. Dimitrakopoulou-Strauss A, et al. Among authors: Sachpekidis C. Clin Transl Imaging. 2017;5(3):183-197. doi: 10.1007/s40336-017-0229-8. Epub 2017 May 3. Clin Transl Imaging. 2017. PMID: 29104864 Free PMC article. Review.
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C. Smailagic N, et al. Among authors: Sachpekidis C. Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629415 Free PMC article. Review.
68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer.
Sachpekidis C, Bäumer P, Kopka K, Hadaschik BA, Hohenfellner M, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):904-912. doi: 10.1007/s00259-018-3936-0. Epub 2018 Jan 23. Eur J Nucl Med Mol Imaging. 2018. PMID: 29362859
The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.
Sachpekidis C, Anwar H, Winkler J, Kopp-Schneider A, Larribere L, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1289-1296. doi: 10.1007/s00259-018-3972-9. Epub 2018 Feb 24. Eur J Nucl Med Mol Imaging. 2018. PMID: 29478079 Clinical Trial.
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.
Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A. Anwar H, et al. Among authors: Sachpekidis C. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):376-383. doi: 10.1007/s00259-017-3870-6. Epub 2017 Nov 10. Eur J Nucl Med Mol Imaging. 2018. PMID: 29124281 Clinical Trial.
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer.
Sachpekidis C, Kopka K, Eder M, Hadaschik BA, Freitag MT, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Clin Nucl Med. 2016 Nov;41(11):e473-e479. doi: 10.1097/RLU.0000000000001349. Clin Nucl Med. 2016. PMID: 27607173 Free article.
18F-FDG PET/CT of Papillary Carcinoma in a Lateral Thyroglossal Duct Cyst.
Sachpekidis C, Dettmer MS, Weidner S, Giger R, Wartenberg J. Sachpekidis C, et al. Clin Nucl Med. 2017 Aug;42(8):e371-e374. doi: 10.1097/RLU.0000000000001712. Clin Nucl Med. 2017. PMID: 28525461 Free article.
65 results
Jump to page
Feedback